844
Views
0
CrossRef citations to date
0
Altmetric
Research Article

The impacts of resveratrol on the retinal degeneration in a rat model of retinitis pigmentosa induced by alkylation: an in-vivo study

, , , , , , , & show all
Pages 138-148 | Received 05 Sep 2022, Accepted 12 Mar 2023, Published online: 26 Jun 2023

References

  • Banu SK, Stanley JA, Sivakumar KK, Arosh JA, Burghardt RC. 2016. Resveratrol protects the ovary against chromium-toxicity by enhancing endogenous antioxidant enzymes and inhibiting metabolic clearance of estradiol. Toxicol Appl Pharmacol. 303:65–78. doi:10.1016/j.taap.2016.04.016.
  • Chan SH, Hung CH, Shih JY, Chu PM, Cheng YH, Lin HC, Hsieh PL, Tsai KL. 2018. Exercise intervention attenuates hyperhomocysteinemia-induced aortic endothelial oxidative injury by regulating SIRT1 through mitigating NADPH oxidase/LOX-1 signaling. Redox Biol. 14:116–125. doi:10.1016/j.redox.2017.08.016.
  • Chen T, Tao Y, Yan W, Yang G, Chen X, Cao R, Zhang L, Xue J, Zhang Z. 2016. Protective effects of hydrogen-rich saline against N-methyl-N-nitrosourea-induced photoreceptor degeneration. Exp Eye Res. 148:65–73. doi:10.1016/j.exer.2016.05.017.
  • de Bruin DM, Broekgaarden M, van Gemert MJ, Heger M, de la Rosette JJ, Van Leeuwen TG, Faber DJ. 2016. Assesment of apoptosis induced changes in scattering using optical coherence tomography. J Biophotonics. 9:913–923. doi:10.1002/jbio.201500198.
  • Dick AD, Carter D, Robertson M, Broderick C, Hughes E, Forrester JV, Liversidge J. 2003. Control of myeloid activity during retinal inflammation. J Leukoc Biol. 74:161–166. doi:10.1189/jlb.1102535.
  • Fang M, Guo WR, Park Y, Kang HG, Zarbl H. 2015. Enhancement of NAD+-dependent SIRT1 deacetylase activity by methylselenocysteine resets the circadian clock in carcinogen-treated mammary epithelial cells. Oncotarget. 6:42879–42891. doi:10.18632/oncotarget.6002.
  • Fenner A. 2017. Prostate cancer: resveratrol inhibits the AR. Nat Rev Urol. 14(11):642. doi:10.1038/nrurol.2017.159.
  • Fischer MD, McClements ME, Martinez-Fernandez DLCC, Bellingrath JS, Dauletbekov D, Ramsden SC, Hickey DG, Barnard AR, MacLaren RE. 2017. Codon-optimized RPGR improves stability and efficacy of AAV8 gene therapy in two mouse models of X-linked retinitis pigmentosa. Mol Ther. 25:1854–1865. doi:10.1016/j.ymthe.2017.05.005.
  • Kang K, Yu M. 2017. Protective effect of sulforaphane against retinal degeneration in the Pde6rd10 mouse model of retinitis pigmentosa. Curr Eye Res.. 42(12):1684–1688. doi:10.1080/02713683.2017.1358371.
  • Karlstetter M, Scholz R, Rutar M, Wong WT, Provis JM, Langmann T. 2015. Retinal microglia: just bystander or target for therapy? Prog Retin Eye Res. 45:30–57. doi:10.1016/j.preteyeres.2014.11.004.
  • Kelbsch C, Maeda F, Lisowska J, Lisowski L, Strasser T, Stingl K, Wilhelm B, Wilhelm H, Peters T. 2017. Analysis of retinal function using chromatic pupillography in retinitis pigmentosa and the relationship to electrically evoked phosphene thresholds. Acta Ophthalmol. 95:e261–e269. doi:10.1111/aos.13259.
  • Kubota S, Kurihara T, Mochimaru H, Satofuka S, Noda K, Ozawa Y, Oike Y, Ishida S, Tsubota K. 2009. Prevention of ocular inflammation in endotoxin-induced uveitis with resveratrol by inhibiting oxidative damage and nuclear factor–κB activation. Invest Ophthalmol Vis Sci. 50:3512–3519. doi:10.1167/iovs.08-2666.
  • Kumar A, Chauhan S. 2016. How much successful are the medicinal chemists in modulation of SIRT1: A critical review. Eur J Med Chem. 119:45–69. doi:10.1016/j.ejmech.2016.04.063.
  • Langmann T. 2007. Microglia activation in retinal degeneration. J Leukoc Biol. 81:1345–1351. doi:10.1189/jlb.0207114.
  • Martin-Merida I, Sanchez-Alcudia R, Fernandez-San JP, Blanco-Kelly F, Perez-Carro R, Rodriguez-Jacy DSL, Almoguera B, Garcia-Sandoval B, Lopez-Molina MI, Avila-Fernandez A, et al. 2017. Analysis of the PRPF31 gene in Spanish autosomal dominant retinitis pigmentosa patients: a novel genomic rearrangement. Invest Ophthalmol Vis Sci. 58:1045–1053. doi:10.1167/iovs.16-20515.
  • McCulloch DL, Marmor MF, Brigell MG, Hamilton R, Holder GE, Tzekov R, Bach M. 2015. ISCEV standard for full-field clinical electroretinography (2015 update). Doc Ophthalmol. 130:1–12. doi:10.1007/s10633-014-9473-7.
  • Mimura T, Kaji Y, Noma H, Funatsu H, Okamoto S. 2013. The role of SIRT1 in ocular aging. Exp Eye Res. 116:17–26. doi:10.1016/j.exer.2013.07.017.
  • Nagineni CN, Raju R, Nagineni KK, Kommineni VK, Cherukuri A, Kutty RK, Hooks JJ, Detrick B. 2014. Resveratrol suppresses expression of VEGF by human retinal pigment epithelial cells: potential nutraceutical for age-related macular degeneration. Aging Dis. 5:88–100. doi:10.14366/AD.2014.050088.
  • Nakajima M, Yuge K, Senzaki H, Shikata N, Miki H, Uyama M, Tsubura A. 1996. Photoreceptor apoptosis induced by a single systemic administration of N-methyl-N-nitrosourea in the rat retina. Am J Pathol. 148:631–641. PMID 8579125.
  • Noailles A, Maneu V, Campello L, Gomez-Vicente V, Lax P, Cuenca N. 2016. Persistent inflammatory state after photoreceptor loss in an animal model of retinal degeneration. Sci Rep. 6:33356. doi:10.1038/srep33356.
  • Pacholec M, Bleasdale JE, Chrunyk B, Cunningham D, Flynn D, Garofalo RS, Griffith D, Griffor M, Loulakis P, Pabst B, et al. 2010. SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1. J Biol Chem. 285:8340–8351. doi:10.1074/jbc.M109.088682.
  • Petrovic MG. 2014. Sirt1, a negative regulator of matrix metalloproteinase-9 in diabetic retinopathy. Invest Ophthalmol Vis Sci. 55:5661. doi:10.1167/iovs.14-14874.
  • Qi LS, Yao L, Liu W, Duan WX, Wang B, Zhang L, Zhang ZM. 2015. Sirtuin type 1 mediates the retinal protective effect of hydrogen-rich saline against light-induced damage in rats. Invest Ophthalmol Vis Sci. 56:8268–8279. doi:10.1167/iovs.15-17034.
  • Tang BL. 2016. Sirt1 and the mitochondria. Mol Cells. 39:87–95. doi:10.14348/molcells.2016.2318.
  • Tao Y, Chen T, Fang W, Peng G, Wang L, Qin L, Liu B, Fei HY. 2015. The temporal topography of the N-Methyl- N-nitrosourea induced photoreceptor degeneration in mouse retina. Sci Rep. 5:18612. doi:10.1038/srep18612.
  • Uehara N, Miki K, Tsukamoto R, Matsuoka Y, Tsubura A. 2006. Nicotinamide blocks N-methyl-N-nitrosourea-induced photoreceptor cell apoptosis in rats through poly (ADP-ribose) polymerase activity and Jun N-terminal kinase/activator protein-1 pathway inhibition. Exp Eye Res. 82:488–495. doi:10.1016/j.exer.2005.08.006.
  • van der Meer FJ, Faber DJ, Aalders MC, Poot AA, Vermes I, van Leeuwen TG. 2010. Apoptosis- and necrosis-induced changes in light attenuation measured by optical coherence tomography. Lasers Med Sci. 25:259–267. doi:10.1007/s10103-009-0723-y.
  • Wang X, Zhao L, Zhang Y, Ma W, Gonzalez SR, Fan J, Kretschmer F, Badea TC, Qian HH, Wong WT. 2017. Tamoxifen provides structural and functional rescue in murine models of photoreceptor degeneration. J Neurosci. 37:3294–3310. doi:10.1523/JNEUROSCI.2717-16.2017.
  • Williams LD, Burdock GA, Edwards JA, Beck M, Bausch J. 2009. Safety studies conducted on high-purity trans-resveratrol in experimental animals. Food Chem Toxicol. 47:2170–2182. doi:10.1016/j.fct.2009.06.002.
  • Wood JG, Rogina B, Lavu S, Howitz K, Helfand SL, Tatar M, Sinclair D. 2004. Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature. 430:686–689. doi:10.1038/nature02789.
  • Yan W, Long P, Wei D, Yan W, Zheng X, Chen G, Wang J, Zhang Z, Chen T, Chen M. 2020. Protection of retinal function and morphology in MNU-induced retinitis pigmentosa rats by ALDH2: an in-vivo study. BMC Ophthalmol. 20:55. doi:10.1186/s12886-020-1330-8.
  • Yang X, Xu S, Qian Y, Xiao Q. 2017. Resveratrol regulates microglia M1/M2 polarization via PGC-1α in conditions of neuroinflammatory injury. Brain Behav Immun. 64:162–172. doi:10.1016/j.bbi.2017.03.003.
  • Zhang S, Gao L, Liu X, Lu T, Xie C, Jia J. 2017. Resveratrol attenuates microglial activation via SIRT1-SOCS1 pathway. Evid Based Complement Alternat Med. 2017:8791832. doi:10.1155/2017/8791832.